SEMAGLUTIDE
Minimum order 2 vials or 2 pens — delivery in 2 weeks
−14.9% body weight in 68 weeks — and the only one of the group proven to reduce heart attack and stroke, in 17,604 people.
Illustrations of the product — not photos of a specific batch.
Not the strongest in the category. But it flattens visceral fat.
In STEP 6, 401 people from East Asia, visceral fat area fell 40.0% on semaglutide 2.4 mg, vs 6.9% on placebo 1. That's not the fat you see in the mirror — it's the fat sitting around your organs and keeping inflammation high.
And now the number you need to know before you buy, and nobody tells you. A network meta-analysis of 22 randomized trials with 2,258 people: on a GLP-1 agonist you lose 3.55 kg of weight on average — of which 0.86 kg is lean mass. That means roughly one in every four kilos that comes off isn't fat 2.
And the particularly unpleasant part: the same analysis ranks tirzepatide 15 mg and semaglutide 2.4 mg as the most effective for weight and fat — and at the same time among the least effective at preserving lean mass 2. Whatever takes you down fast takes muscle with it too.
The mitigating point, because it exists and it's only honest to write it: lean mass as a percentage of the body didn't fall 2, and in a second review of 1,541 people it rose 3. You become proportionally leaner. But the kilos of muscle that went are gone — and the same review found losses reaching up to 40% of total weight loss in the larger trials 3.
What it means in practice. It doesn't mean “don't take it”. It means that here, resistance training and protein aren't just a good habit — they're the reason you'll keep what you built. Without them, one in every four kilos that comes off is your own muscle.
And the reason it stays on the table anyway: it's the only molecule on this page with an outcomes trial of 17,604 people — 20% fewer cardiovascular events over almost 40 months 4. No other has that kind of track record on paper, and no weight-loss percentage replaces it.
And three numbers the scale doesn't show. Blood sugar: HbA1c −1.86% in 40 weeks 6. Heart: 17,604 people, 20% fewer cardiovascular events over almost 40 months 4. Kidneys: 3,533 people with kidney disease — the trial was stopped early because the benefit was clear: kidney events 24% fewer, death from any cause 20% lower 5.
Four formats. Choose by what suits you, not by what sounds better.
Syringes: four single-dose, pre-filled at your dose — no measuring, no drawing up, no chance of getting lost in the zeros. One month. Pen: the same four doses in one device, with the extra charge.
Watch the pen number. “1 × 2 mg” isn't 2 mg in one go — it's 4 × 0.5 mg, a month in one pen. Always four times the dose, because it carries all four weeks.
Vial: plain powder, the cheapest per mg. You do the work — reconstitution, calculation, your own syringes. Reconstituted vial: the same, dissolved in 2 mL bacteriostatic water with 4 syringes included, +10 €.
The trade-off: the solution has a clock, the powder doesn't. Once reconstituted it needs the fridge and won't wait months. If you're starting now, it's convenient; if you're stocking up, get the powder.
Four formats, and the difference is how much of the work you do. Syringes: none. Pen: none, and everything in one device. Reconstituted vial: arrives ready, with syringes. Lyophilized powder: you prepare it, and it's the most stable over time. Choose by what you'll actually do — not by what sounds more serious.
1 is in an East Asian population; body composition differs, and the visceral fat figure doesn't transfer one-to-one. 2 and 3 cover the GLP-1 agonist class, not just semaglutide.
Semaglutide is the most tested name on this whole page — and that alone is something to celebrate.
It works through a single receptor, GLP-1: it curbs appetite, slows stomach emptying, balances blood sugar. One key, but a key that opens many doors.
−14.9% in 68 weeks. Almost one kilo in every six, in 1,961 people, vs just −2.4% on placebo 1. A number that needs no decoration.
And the most beautiful part isn't even the scale. In 17,604 people with cardiovascular disease, semaglutide delivered 20% fewer cardiovascular events over almost 40 months of follow-up 2. Your heart gets the chance to say thank you.
The honesty it deserves: results vary from person to person, and these numbers come from tightly controlled clinical trials — not from a promise of personal results.
A research-use product, not for human dosing. Lyophilized, stable in the fridge before reconstitution; after that, chilled, dark, and rolled — never shaken.
It isn't the strongest. It's the most proven. And on this page, that's a title of its own.
Weight numbers first: −14.9% in 68 weeks, vs −2.4% on placebo, in 1,961 people 1. Less than tirzepatide, less than retatrutide. You know it and we know it.
And now the number no other molecule here has. The SELECT trial enrolled 17,604 people with cardiovascular disease and excess weight, without diabetes, and followed them for an average of almost 40 months. Death from cardiovascular causes, heart attack or stroke: 6.5% vs 8.0% — that's 20% fewer events 2.
That isn't “you lose weight”. It's an outcomes trial: it measured what happened to people, not what the scale showed. No other product on this page has a placebo-controlled trial like that.
How it works: a GLP-1 agonist, one receptor. It cuts appetite, slows stomach emptying, regulates blood sugar. Simple, targeted, and studied more than anything else in the category.
In practice: slow, gradual dose escalation helps tolerability — that's why it exists, and that's why it's worth sticking to. The body needs time to adjust, and that's normal.
The formats, and what changes with each one.
Syringes. Four single-dose syringes — one month, one a week. Each one pre-filled with the dose you chose. No measuring, no drawing up, no calculating: open one and you're done. The price you see is the price.
Pen. The same four doses in a single device, with the extra charge shown next to it. And this number needs attention, because it throws people: “1 × 2 mg pen” does not mean a 2 mg dose. It means four doses of 0.5 mg — the whole month in one pen. The pen always holds four times your dose, because it carries all four.
Vial. The powder, lyophilized. These aren't doses — it's a quantity, and you split it yourself. It needs reconstitution, your own syringes, and knowing what you're doing. It's the cheapest route per milligram, and the most demanding.
Reconstituted vial. The same vial, already dissolved in 2 mL bacteriostatic water, with four syringes included, +10 €. We do it ourselves, using aseptic technique.
And the trade-off, because there is one: once it's dissolved, the stability clock starts and doesn't stop. Lyophilized powder waits; the solution doesn't — it needs the fridge, darkness, and use within a reasonable window. You buy yourself time by giving up shelf life. If that suits you, it's worth it; if the product is going to sit, get the powder.
Beyond weight, three numbers. Blood sugar: HbA1c −1.86% in 40 weeks 4. Heart: 17,604 people, 20% fewer cardiovascular events over almost 40 months 2. Kidneys: 3,533 people with kidney disease — the trial was stopped early because the benefit was clear: kidney events 24% fewer, death from any cause 20% lower 3.
Four formats, and the difference is how hands-on you want to be. The syringes need nothing: open and you're done. The pen holds all four in one device. The reconstituted vial arrives ready, with the syringes included. Lyophilized powder is the most stable over time — but you prepare it yourself. Choose based on your routine, not on price: a ten-euro saving isn't worth a vial that just sits there.
Intro offer: 4 × 0.25 mg syringes · Syringes: 4 × 0.25 mg syringes, 4 × 0.5 mg syringes, 4 × 1 mg syringes, 4 × 1.7 mg syringes, 4 × 2.4 mg syringes · Pens: 1 × 1 mg pen, 1 × 2 mg pen, 1 × 4 mg pen, 1 × 6.8 mg pen, 1 × 9.6 mg pen · Vial: 5 mg vial, reconstituted 5 mg vial + 4 syringes, 10 mg vial, reconstituted 10 mg vial + 4 syringes.
It's sold out. Write to us and we'll tell you when it's back — or we'll let you know as soon as it's in.
€3 shipping + €3 cash-on-delivery fee. For orders of 2 vials or pens or more, shipping and the cash-on-delivery fee are free. Delivery time depends on the courier.
Cash on delivery, paid to the courier when it arrives. For an electronic money transfer (PayPal, Revolut, Wise, crypto), email us for the details: ellinikapeptidia@gmail.com
Yes: you have a 14-day right of withdrawal from delivery, as long as the seal is intact. Return costs are yours, unless the product was faulty or wrong. Terms of Use
Want something you don't see here? Write to us — we reply.
Related products
from €79.20 to €140
Minimum order 2 vials or 2 pens — delivery in 2 weeks
It's not GLP-1 — it's amylin, the other satiety switch. Together with semaglutide it delivered −20.4% in 3,417 people.
from €112.80 to €128.80
Minimum order 2 vials or 2 pens — delivery in 2 weeks
GLP-1 and glucagon — no GIP. −14.0% in 48 weeks, and discontinuations due to side effects on par with placebo.
from €139.20 to €155.20
Minimum order 2 vials or 2 pens — delivery in 2 weeks
Dual GLP-1 and glucagon receptor agonist: in phase 2 (n=387) it produced up to −14.9% body weight at 46 weeks.
from €102.40 to €118.40
Minimum order 2 vials or 2 pens — delivery in 2 weeks
In a 48-week phase 2 RCT (263 adults with obesity), weekly eloralintide produced dose-dependent weight loss of up to −20% at the 9 mg dose, versus −0.4% with placebo.
from €44 to €176
Minimum order 2 vials or 2 pens — delivery in 2 weeks
−24.2% body weight in 48 weeks, and −82% liver fat. A triple GLP-1, GIP and glucagon agonist: it makes you eat less and burn more.
from €44 to €176
Minimum order 2 vials or 2 pens — delivery in 2 weeks
−20.9% body weight in 72 weeks, in a study of 2,539 people. A dual GLP-1 and GIP agonist: two switches instead of one — which is why the numbers are in a different league from monotherapy.
€0
Fill in and send. A person replies, not an automated message.